A brief history of long circulating nanoparticles

Macrophage membrane coated nanoparticles: a biomimetic approach for enhanced and targeted delivery

(2022) Nafeesa Khatoon et al.   Biomaterials Science

PEGylated Liposomes Accumulate in the Areas Relevant to Skin Toxicities via Passive Extravasation across “Leaky” Endothelium

(2022) Yue Li et al.   ACS Nano

Critical issues and pitfalls in serum and plasma handling for complement analysis in nanomedicine and bionanotechnology

(2022) S. Moein Moghimi et al.   Nano Today

Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking

(2021) Lin-Ping Wu et al.   Nature Communications

The wHole Story About Fenestrations in LSEC

(2021) Karolina Szafranska et al.   Frontiers in Physiology

Complement opsonization of nanoparticles: Differences between humans and preclinical species

(2021) Yue Li et al.   JOURNAL OF CONTROLLED RELEASE

The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers

(2021) Wufa Fan et al.   Acta Pharmaceutica Sinica B

Complement activation by drug carriers and particulate pharmaceuticals: Principles, challenges and opportunities

(2020) S. Moein Moghimi et al.   ADVANCED DRUG DELIVERY REVIEWS

A Nanoprimer To Improve the Systemic Delivery of siRNA and mRNA

(2020) Nell R. M. Saunders et al.   NANO LETTERS

Overcoming Nanoparticle-Mediated Complement Activation by Surface PEG Pairing

(2020) Martina Pannuzzo et al.   NANO LETTERS

Just eat it: A review of CD47 and SIRP-α antagonism

(2020) Bryan Oronsky et al.   SEMINARS IN ONCOLOGY

Stealth Coating of Nanoparticles in Drug-Delivery Systems

(2020) See Yee Fam et al.   Nanomaterials

Engineering precision nanoparticles for drug delivery

(2020) Michael J. Mitchell et al.   NATURE REVIEWS DRUG DISCOVERY

Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application

(2019) Qing Xia et al.   Acta Pharmaceutica Sinica B

The Interplay between Blood Proteins, Complement, and Macrophages on Nanomedicine Performance and Responses

(2019) Seyed Moein Moghimi et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Red Blood Cells: Chasing Interactions

(2019) Virginia Pretini et al.   Frontiers in Physiology

Accelerated blood clearance of nanoemulsions modified with PEG-cholesterol and PEG-phospholipid derivatives in rats: The effect of PEG-lipid linkage and PEG molecular weight

(2019) Mengyang Liu et al.   MOLECULAR PHARMACEUTICS

C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes

(2018) Regina Tavano et al.   ACS Nano

Dense and Dynamic Polyethylene Glycol Shells Cloak Nanoparticles from Uptake by Liver Endothelial Cells for Long Blood Circulation

(2018) Hao Zhou et al.   ACS Nano

Reticuloendothelial System Pre-Block Strategy to Improve Tumor Targeting Efficacy for Hyaluronic Acid Related Drug Delivery System

(2018) Fulei Liu et al.   Journal of Biomedical Nanotechnology

Cell Membrane-Camouflaged Nanoparticles: A Promising Biomimetic Strategy for Cancer Theragnostics

(2018) Veena Vijayan et al.   Polymers

Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles

(2018) Vivian P. Vu et al.   Nature Nanotechnology

Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes

(2017) Peter Popp Wibroe et al.   Nature Nanotechnology

Improved Tumor Uptake by Optimizing Liposome Based RES Blockade Strategy

(2017) Xiaolian Sun et al.   Theranostics

Long Circulating Polymeric Nanoparticles for Gene/Drug Delivery

(2017) Jiaming Hu et al.   CURRENT DRUG METABOLISM

PEGylation as a strategy for improving nanoparticle-based drug and gene delivery

(2016) Jung Soo Suk et al.   ADVANCED DRUG DELIVERY REVIEWS

An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome

(2016) Peter P. Wibroe et al.   JOURNAL OF CONTROLLED RELEASE

Platelet mimicry: The emperor's new clothes?

(2016) Seyed Moein Moghimi et al.   Nanomedicine-Nanotechnology Biology and Medicine

Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake

(2015) Swetha Inturi et al.   ACS Nano

Dendrimers in Medicine: Therapeutic Concepts and Pharmaceutical Challenges

(2015) Lin-ping Wu et al.   BIOCONJUGATE CHEMISTRY

Exploiting shape, cellular-hitchhiking and antibodies to target nanoparticles to lung endothelium: Synergy between physical, chemical and biological approaches

(2015) Aaron C. Anselmo et al.   BIOMATERIALS

Disulfide-bridged cleavable PEGylation in polymeric nanomedicine for controlled therapeutic delivery

(2015) Haiqing Dong et al.   Nanomedicine

Nanoparticle biointerfacing by platelet membrane cloaking

(2015) Che-Ming J. Hu et al.   NATURE

Anti-PEG immunity: emergence, characteristics, and unaddressed questions

(2015) Qi Yang et al.   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications

(2014) R. M. Kannan et al.   JOURNAL OF INTERNAL MEDICINE

Smart pH- and reduction-dual-responsive folate–PEG-coated polymeric lipid vesicles for tumor-triggered targeted drug delivery

(2014) Sheng Wang et al.   Nanoscale

Structural basis for sialic acid–mediated self-recognition by complement factor H

(2014) Bärbel S Blaum et al.   Nature Chemical Biology

pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells

(2013) Da-Wen Dong et al.   BIOMATERIALS

The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage

(2013) Amr S. Abu Lila et al.   JOURNAL OF CONTROLLED RELEASE

Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles

(2013) P. L. Rodriguez et al.   SCIENCE

Doxil® — The first FDA-approved nano-drug: Lessons learned

(2012) Yechezkel (Chezy) Barenholz   JOURNAL OF CONTROLLED RELEASE

Material properties in complement activation

(2011) S. Moein Moghimi et al.   ADVANCED DRUG DELIVERY REVIEWS

Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective

(2011) S.M. Moghimi et al.   Annual Review of Pharmacology and Toxicology

Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

(2011) C.-M. J. Hu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Distinct Polymer Architecture Mediates Switching of Complement Activation Pathways at the Nanosphere−Serum Interface: Implications for Stealth Nanoparticle Engineering

(2010) Islam Hamad et al.   ACS Nano

Self inhibition of phagocytosis: The affinity of ‘marker of self’ CD47 for SIRPα dictates potency of inhibition but only at low expression levels

(2010) Richard K. Tsai et al.   BLOOD CELLS MOLECULES AND DISEASES

Targeting of a Mutant Plasminogen Activator to Circulating Red Blood Cells for Prophylactic Fibrinolysis

(2009) S. Zaitsev et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Lymph Circulation in the Liver

(2008) Osamu Ohtani et al.   Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology

Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells

(2008) Richard K. Tsai et al.   JOURNAL OF CELL BIOLOGY

Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives

(2008) H XU et al.   JOURNAL OF CONTROLLED RELEASE